UBS Group’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-785,300
Closed -$974K 10517
2025
Q4
$974K Buy
+785,300
New +$1.1M ﹤0.01% 5606

Other funds holding BMEA

UBS Group's BMEA Position: Q2 2026 in Review

UBS Group reduced its Biomea Fusion (BMEA) stake by 14% in Q2 2026, selling an estimated $106K and leaving 444,728 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #6068.

UBS Group first reported a position in BMEA in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.95M in Q1 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • UBS Group held 444,728 shares of Biomea Fusion worth $654K as of Q2 2026.
  • UBS Group sold 70,827 Biomea Fusion shares in Q2 2026, an estimated $106K.
  • Biomea Fusion made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6068 holding.
  • UBS Group first reported a position in Biomea Fusion in Q3 2021 and has held it in 20 quarters since.
  • UBS Group's Biomea Fusion position peaked at $3.95M in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.